Thursday, April 8, 2010

Spare swine flu vaccine - government failure or good planning?


The answer to that probably lies in the future, next winter, when we will discover whether the buffer stocks of 34 million unused swine flu jabs is needed or not.
In the emergency last summer the government contracted to buy 120 million jabs from the two manufacturers, GlaxoSmith Kline and Baxter, but then reduced the order to just 44 million as the emergency petered out. Only 6million of those have actually been used, nearly 4 million are being given to the World Health Organisation for use in Africa, leaving 34 million on the shelf

No comments:

Post a Comment